Vascular Stents Market Size, Share & Trends by 2034

Coverage: By Component (General Surgery Systems, Surgical Services, Other Components); Type (Orthopedic Surgery, General Surgery, Gynecological Surgery, Urological Surgery, Neurosurgery Surgery, Other Surgeries); End User (Hospitals, Ambulatory Surgical Centers, Other End Users), and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPMD00002338
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : April 17, 2026
Vascular Stents Market Size, Share & Trends by 2034
Report Date: April 17, 2026   |   Report Code: TIPMD00002338 Email: sales@theinsightpartners.com

2025 Market Size

US$ 14.9 Bn

Base year value

2034 Forecast

US$ 25.83 Bn

Projected by 2034

CAGR 2026-2034

6.31 %

Growth rate

Addressable Market

US$ 184.38 Bn

(2026-2034)

The global vascular stents market size is projected to reach US$ 25.83 billion by 2034 from US$ 14.9 billion in 2025. The market is anticipated to register a CAGR of 6.31% during the forecast period 2026-2034.

MARKET OVERVIEW


Vascular stents are small wired net tubes that used to treat narrow or blocked arteries to improve blood flow in the arteries. The method for placement of a vascular stent into the body is called as vascular stenting. The stents are usually made up of fabric and metal that used in a procedure called percutaneous coronary intervention or angioplasty that commonly used in a management of coronary artery disease, renal (kidney) artery narrowing, peripheral vascular diseases, diabetes and others. A vascular stent is placed into a blood vessel that allowing normal flow of blood and helps to reduce the chances of heart attack and chest pain.


MARKET SCOPE


The "Global Vascular Stents Market Analysis to 2034" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of the vascular stents market with detailed market segmentation by type, end user, and geography. The report provides key statistics on the market status of the leading vascular stents market players and offers key trends and opportunities in the market.


MARKET SEGMENTATION



  • Based on type, the market is segmented into coronary stents, peripheral stents, EVAR stent grafts.

  • Based on the end user the market is segmented as hospitals, cardiac centers, ambulatory surgical centers.


Market Assessment and Insights

  • Global market for Vascular Stents was valued at US$ 14.90 Billion in 2025
  • Annual market size is expected to reach US$ 25.83 Billion by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 184.38 Billion
  • Market is anticipated to register a CAGR of 6.31% during the forecast period
  • The United States represents a key market, supported by Increasing Incidence of Cardiovascular Diseases, Growing Awareness and Accessibility, Rising Healthcare Expenditur, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Expansion into Emerging Markets, Focus on Peripheral Vascular Stents are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including Medtronic, Boston Scientific Corporation, B. Braun Melsungen AG, TERUMO CORPORATION, JOTEC GmbH, Lombard Medical, C. R. Bard, Inc., Meril Life Sciences Pvt. Ltd., ENDOLOGIX, INC., MicroPort Scientific Corporation, while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Vascular Stents Market: Strategic Insights

vascular-stents-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

MARKET DYNAMICS


Drivers



  • Rising minimally invasive procedures

  • Growing innovations in stenting technologies

  • Rising incidence of vascular diseases


Restraints



  • Availability of alternative treatment methods for vascular diseases


Vascular Stents Market Report Scope

Report Attribute Details
Market size in 2025 US$ 14.9 Billion
Market Size by 2034 US$ 25.83 Billion
Global CAGR (2026 - 2034) 6.31%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Component
  • General Surgery Systems
  • Surgical Services
  • Other Components
By Type
  • Orthopedic Surgery
  • General Surgery
  • Gynecological Surgery
  • Urological Surgery
  • Neurosurgery Surgery
  • Other Surgeries
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End Users
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Medtronic
  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • TERUMO CORPORATION
  • JOTEC GmbH
  • Lombard Medical
  • C. R. Bard, Inc.
  • Meril Life Sciences Pvt. Ltd.
  • ENDOLOGIX, INC.
  • MicroPort Scientific Corporation

Vascular Stents Market Players Density: Understanding Its Impact on Business Dynamics

The Vascular Stents Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

vascular-stents-market-cagr


REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2034 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The vascular stents market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.


The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the vascular stents market in these regions.


IMPACT OF COVID-19 ON VASCULAR STENTS MARKET


COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 pandemic significantly impacted the market for vascular stents. According to a 2021 report by Censis Technologies, Inc., many elective surgeries were postponed due to the pandemic. However, when they resumed, operating rooms and technicians had to deal with a huge backlog, while continuing to work around COVID. This unveiled the need for effective vascular stents as sterile supply processing and equipment shortages became an issue.


MARKET PLAYERS


The report covers key developments in the vascular stents market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from vascular stents market are anticipated to lucrative growth opportunities in the future with the rising demand for vascular stents in the global market.


The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the vascular stents market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.



  • Medtronic

  • Boston Scientific Corporation

  • B. Braun Melsungen AG

  • TERUMO CORPORATION

  • JOTEC GmbH

  • Lombard Medical

  • C. R. Bard, Inc.

  • Meril Life Sciences Pvt. Ltd.

  • ENDOLOGIX, INC.

  • MicroPort Scientific Corporation

Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA